Posted by Teri Schroder on Jun 7th, 2016
Valeant Pharmaceuticals International Inc. (NYSE:VRX) shares plummeted Tuesday as new Chief Executive Officer Joseph Papa reduced the company’s 2016 earnings and sales forecasts. The earnings forecast for this year has been reduced...
More of this article »